Published in Clinical Trials Week, November 14th, 2005
The study, entitled PRECiSE 2, found that a significantly higher proportion of patients who responded to an induction regimen of 400 mg Cimzia(tm) at weeks zero, two and six, were able to maintain clinical response and achieve remission by week 26 when given a single injection every 4 weeks, compared to those treated with placebo. A regulatory submission for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Trials Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.